Determining invasiveness of prostatic adenocarcinoma

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 71, 435 405, 435 4052, 530386, 5303871, 5303877, C12Q 100, G01N 3353, C07K 1600

Patent

active

058306404

ABSTRACT:
The invention relates to methods for determining metastatic potential of tumors and to methods and compositions for inhibiting or preventing metastasis of cancers. In one aspect, the invention provides a method to determine metastatic potential of tumors, particularly prostatic tumors. In this regard the invention relates to determining protein or mRNA of effectors of arachadonic acid release to gauge metastatic potential, particularly uteroglobin protein or mRNA to determine metastatic potential of prostatic tumors.
The invention also relates to methods and compositions that prevent or inhibit metastasis of cancers. In this regard, the invention particularly relates to methods and compositions that inhibit arachidonic acid, those that inhibit phospholipase A.sub.2. More particularly in this regard, the invention relates to uteroglobin or muteins, peptide analogs or mimetics of uteroglobin and lipocortins or muteins, peptide analogs, or mimetics of lipocortins that inhibit metastasis. Especially it relates to methods and compositions in which uteroglobins, particularly human uteroglobins, inhibit or prevent metastasis of cancer, particularly prostatic cancer.

REFERENCES:
Manyak et al (J. Immunol, 140: 176-182), 1988.
Tibes et al (Expert Opin. Invest. Drugs, 1997, 6: 279-298).
Mayer et al (Expert Opin Invest Drugs, 1996, 5/5: 535-553.
Dannhorn et al, J. Immunol. Meth., 119: 223-230, 1989.
Cerbon et al (J. Steroid Biochem, 36: 1-6), 1990.
Lopez de Haro et al (FEBS Letts 232: 351-353), 1988.
Aumuller et al (Histochemistry, 83: 413-417), 1985.
Frandsen et al.; Fibrinolysis, 1992: 6 Suppl. 4: 71-76).
Leyton et al (Cancer Res, 1994, 54: 3696-3699).
Stone et al., Int J. Cancer, 1978, 21: 274-281.
Hill, The Basic Science of Oncology; Tannock et al, Eds, McGraw Hill, NY, 1992 pp. 178-195.
Osband & Ross, Immunology Today, 1990, 11: 193-195.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Determining invasiveness of prostatic adenocarcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Determining invasiveness of prostatic adenocarcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Determining invasiveness of prostatic adenocarcinoma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-687809

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.